HEIDELBERG PHARMA AG (HPHA.DE) Stock Balance Sheet
FRA:HPHA • DE000A11QVV0
Current stock price
2.74 EUR
-0.04 (-1.44%)
Last:
| 2025 (2025-11-30) | 2024 (2024-11-30) | 2023 (2023-11-30) | 2022 (2022-11-30) | 2021 (2021-11-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 14.98M | 29.42M | 43.44M | 81.33M | 6.14M | |||
| Receivables | 2.35M | 5.95M | 2.32M | 1.45M | 1.45M | |||
| Inventories | 10.61M | 11.82M | 10.49M | 4.58M | 745.90K | |||
| Other Current Assets | 397.90K | 375.00K | 382.70K | 513.30K | 676.30K | |||
| Total Current Assets | 28.33M | 47.57M | 56.63M | 87.88M | 9.01M | |||
| Non-Current Assets | ||||||||
| PPE Net | 912.10K | 3.49M | 3.85M | 3.72M | 3.67M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Goodwill | 6.11M | 6.11M | 6.11M | 6.11M | 6.11M | |||
| Intangibles | 2.72M | 2.75M | 2.79M | 2.84M | 2.90M | |||
| Other Non-Current Assets | 36.10K | 779.30K | 4.80K | 4.90K | 4.90K | |||
| Total Non-Current Assets | 9.81M | 13.15M | 13.72M | 12.70M | 12.72M | |||
| TOTAL ASSETS | 38.14M | 60.72M | 70.35M | 100.58M | 21.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 5.65M | 15.79M | 10.46M | |||
| Current Portion Of LT Debt. | 101.80K | 115.50K | 113.20K | 94.40K | 91.10K | |||
| Accrued Expenses | 911.00K | 1.13M | 1.17M | 3.99M | 2.98M | |||
| Accounts Payable | 7.16M | 5.55M | 7.88M | 3.05M | 903.00K | |||
| Other Current Liabilities | 3.03M | 1.20M | 4.97M | 5.02M | 491.30K | |||
| Total Current Liabilities | 11.21M | 8.00M | 19.78M | 27.93M | 14.93M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 36.79M | 21.86M | 70.40K | 100.40K | 75.60K | |||
| Other Non-Current Liabilities | 1.05M | 0.00 | 1.17M | 5.90M | 23.40K | |||
| Total Non-Current Liabilities | 37.84M | 21.86M | 1.24M | 6.00M | 99.00K | |||
| TOTAL LIABILITIES | 49.05M | 29.85M | 21.01M | 33.94M | 15.03M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -362.69M | -320.52M | -302.04M | -284.68M | -265.53M | |||
| Additional Paid In Capital | 304.99M | 304.78M | 304.78M | 304.74M | 238.05M | |||
| Common Shares | 46.78M | 46.60M | 46.60M | 46.58M | 34.18M | |||
| Other Shareholders' Equity | 0.00 | N/A | 0.00 | N/A | N/A | |||
| Shares Outstanding | 46.78M | 46.60M | 46.60M | 46.58M | 34.18M | |||
| Tangible Book Value per Share | -0.42 | 0.47 | 0.87 | 1.24 | -0.07 | |||
| Total Shareholders' Equity | -10.92M | 30.87M | 49.34M | 66.64M | 6.70M | |||
| TOTAL LIABILITIES AND EQUITY | 38.14M | 60.72M | 70.35M | 100.58M | 21.73M | |||
| Statistics | ||||||||
| Debt/Equity | -3.37 | 0.71 | 0.12 | 0.24 | 1.57 | |||
| Current Ratio | 2.53 | 5.95 | 2.86 | 3.15 | 0.60 | |||
| Return On Assets (ROA) | -110.87% | -31.92% | -28.92% | -19.59% | -120.28% | |||
| Return On Equity (ROE) | N/A | -62.79% | -41.24% | -29.56% | -390.21% | |||
All data in EUR , ROIC based on taxRate of 0.30